Export 8 results:
Author Title [ Type(Desc)] Year
Filters: Author is Deye, Gregory A  [Clear All Filters]
Journal Article
S. J. Balevic, Raja, S. M., Randell, R., Deye, G. A., Conrad, T., Nakamura, A., Peyton, D. H., Shotwell, S., Liebman, K., Cohen-Wolkowiez, M., and Guptill, J. T., “Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions.”, Infect Dis Ther, vol. 11, no. 2, pp. 841-852, 2022.
M. B. Laurens, Berry, A. A., Travassos, M. A., Strauss, K., Adams, M., Shrestha, B., Li, T., Eappen, A., Manoj, A., Abebe, Y., Murshedkar, T., Gunasekera, A., Richie, T. L., Lyke, K. E., Plowe, C. V., Kennedy, J. K., Potter, G. E., Deye, G. A., Sim, B. K. L., and Hoffman, S. L., “Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults.”, J Infect Dis, vol. 220, no. 12, pp. 1962-1966, 2019.
M. H. Collins, Potter, G. E., Hitchings, M. D. T., Butler, E., Wiles, M., Kennedy, J. K., Pinto, S. B., Teixeira, A. B. M., Casanovas-Massana, A., Rouphael, N. G., Deye, G. A., Simmons, C. P., Moreira, L. A., Nogueira, M. L., Cummings, D., Ko, A., Teixeira, M. M., and Edupuganti, S., “EVITA Dengue: a Cluster-Randomized Controlled Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral Infection in Brazil”, Trials, vol. 23, no. 1, p. 185, 2022.
S. C. Murphy, Vaughan, A. M., Kublin, J. G., Fishbauger, M., Seilie, A. M., Cruz, K. P., Mankowski, T., Firat, M., Magee, S., Betz, W., Kain, H., Camargo, N., Haile, M. T., Armstrong, J., Fritzen, E., Hertoghs, N., Kumar, S., D Sather, N., Pinder, L. F., Deye, G. A., Galbiati, S., Geber, C., Butts, J., Jackson, L. A., and Kappe, S. H. I., “A Genetically Engineered Plasmodium Falciparum Parasite Vaccine Provides Protection from Controlled Human Malaria Infection”, Sci Transl Med, vol. 14, no. 659, p. eabn9709, 2022.
D. A. J. Friedman-Klabanoff, Berry, A. A., Travassos, M. A., Cox, C., Zhou, Y., Mo, A. X., Nomicos, E. Y. H., Deye, G. A., Pasetti, M. F., and Laurens, M. B., “Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing.”, Vaccine, vol. S0264-410X(20)31590, 2021.
S. C. Murphy, Deye, G. A., B Sim, K. Lee, Galbiati, S., Kennedy, J. K., Cohen, K. W., Chakravarty, S., Kc, N., Abebe, Y., James, E. R., Kublin, J. G., Hoffman, S. L., Richie, T. L., and Jackson, L. A., “PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.”, PLoS Pathog, vol. 17, no. 5, p. e1009594, 2021.
D. Coulibaly, Kone, A. K., Traore, K., Niangaly, A., Kouriba, B., Arama, C., Zeguime, A., Dolo, A., Lyke, K. E., Plowe, C. V., Abebe, Y., Potter, G. E., Kennedy, J. K., Galbiati, S. M., Nomicos, E., Deye, G. A., Richie, T. L., James, E. R., Kc, N., B Sim, K. Lee, Hoffman, S. L., Doumbo, O. K., Thera, M. A., and Laurens, M. B., “PfSPZ-CVac Malaria Vaccine Demonstrates Safety Among Malaria-experienced Adults: A Randomized, Controlled Phase 1 Trial”, EClinicalMedicine, vol. 52, p. 101579, 2022.
D. J. Diemert, Correa-Oliveira, R., Fraga, C. Geraldo, Talles, F., Silva, M. Rezende, Patel, S. M., Galbiati, S., Kennedy, J. K., Lundeen, J. S., Gazzinelli, M. Flavia, Li, G., Hoeweler, L., Deye, G. A., Bottazzi, M. Elena, Hotez, P. J., Sahly, H. M. El, Keitel, W. A., Bethony, J., and Atmar, R. L., “A Randomized, Controlled Phase 1b Trial of the Sm-TSP-2 Vaccine for Intestinal Schistosomiasis in Healthy Brazilian Adults Living in an Endemic Area”, PLoS Negl Trop Dis, vol. 17, no. 3, p. e0011236, 2023.